I'd say that this terminated trial is a different one as there's no mention of the CSF-1 receptor inhibitor, only DCVax+Nivolumab. Also that trial was terminated at latest on July 24, 2020.
LL's presentations including the BMS collaboration trial slides were held in 2021 and 2022.